TRX-818 sodium
CAS No. 1256037-62-3
TRX-818 sodium ( Foslinanib sodium )
产品货号. M11046 CAS No. 1256037-62-3
TRX-818 sodium (Foslinanib sodium ) is an orally bioavailable agent with potential antineoplastic and anti-vasculogenic mimicry (VM) activities.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥3337 | 有现货 |
|
10MG | ¥4965 | 有现货 |
|
25MG | ¥7914 | 有现货 |
|
50MG | ¥10692 | 有现货 |
|
100MG | ¥14418 | 有现货 |
|
200MG | 获取报价 | 有现货 |
|
500MG | 获取报价 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称TRX-818 sodium
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述TRX-818 sodium (Foslinanib sodium ) is an orally bioavailable agent with potential antineoplastic and anti-vasculogenic mimicry (VM) activities.
-
产品描述TRX-818 sodium (Foslinanib sodium ) is an orally bioavailable agent with potential antineoplastic and anti-vasculogenic mimicry (VM) activities, induces cancer cell apoptosis and inhibits cancer cell proliferation; also prevents tumor cell VM by blocking the formation of vasculogenic-like tubular structures through an as of yet undetermined mechanism of action.Liver Cancer Phase 2 Clinical
-
同义词Foslinanib sodium
-
通路Others
-
靶点Other Targets
-
受体Other Targets
-
研究领域Cancer
-
适应症Liver Cancer
化学信息
-
CAS Number1256037-62-3
-
分子量393.22
-
分子式C16H11FNNa2O5P
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESCOC1=C(C2=C(C=C1)NC(=CC2=O)C3=CC(=CC=C3)F)OP(=O)([O-])[O-].[Na+].[Na+]
-
化学全称sodium (2-(3-fluorophenyl)-6-methoxy-4-oxo-1,4-dihydroquinolin-5-yl)phosphonate
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
产品手册
关联产品
-
1,7-Bis(4-hydroxyphe...
(4Z,6E)-5-hydroxy-1,7-bis(4-hydroxyphenyl)hepta-4,6-dien-3-one shows growth inhibitory activity in vitro versus bloodstream forms of African trypanosomes, with the IC(50) value in the range of 1-3 microg/mL.
-
2-(5-methyl-1H-imida...
2-(5-methyl-1H-imidazol-4-yl)ethan-1-amine hydrochloride is a compound used as a molecular building block.
-
Difluprednate
A FDA approved topical corticosteroid indicated for the treatment of inflammation and pain associated with ocular surgery.